Infliximab Powder For Concentrate Solution For Infusion
Infliximab Powder For Concentrate Solution For Infusion

Infliximab Powder For Concentrate Solution For Infusion

Price 18000 INR/ Vial

MOQ : 1 Vial

Infliximab Powder For Concentrate Solution For Infusion Specification

  • Indication
  • Treatment of rheumatoid arthritis, Crohns disease, ankylosing spondylitis, ulcerative colitis, psoriatic arthritis, and plaque psoriasis
  • Salt Composition
  • Infliximab
  • Dosage Form
  • Powder for concentrate solution for infusion
  • Enzyme Types
  • Monoclonal antibody (not an enzyme)
  • Feature
  • High purity, sterile, preservative-free, for hospital and prescription use only
  • Ingredients
  • Infliximab (chimeric IgG1 monoclonal antibody)
  • Application
  • Intravenous infusion after reconstitution and dilution
  • Ph Level
  • Reconstituted solution: typically pH 7.2
  • Temperature Needed For Fermentation
  • Not applicable (biopharmaceutical production)
  • Physical Color/Texture
  • Off-white to pale brown lyophilized powder
  • Fermentation Smell
  • Odorless
  • Enzymatic Activity
  • Not applicable (not an enzyme)
  • Storage Instructions
  • Store at 2C to 8C (Refrigerate, do not freeze). Protect from light.
  • Shelf Life
  • 2 years (unopened vial)
 
 

About Infliximab Powder For Concentrate Solution For Infusion



Infliximab Powder For Concentrate Solution For Infusion is a scarce and hot-selling biopharmaceutical, prized for its majestic efficacy in treating formidable autoimmune disorders. Available at a competitive discount, this extraordinary single-use vial contains 100 mg of infliximab lyophilized powder that reconstitutes to 10 mg/mL for intravenous administration. Only compatible with 0.9% Sodium Chloride Injection, this high-purity formulation must be filtered and is reserved for prescription use to ensure patient safety. Strict batch tracking ensures traceability, making this product indispensable for hospitals, suppliers, and distributors.

Application and Therapeutic Use

Infliximab Powder For Concentrate Solution For Infusion is administered exclusively via intravenous infusion, following careful reconstitution with sterile water. Used as a potent TNF-alpha inhibitor, it is indicated for serious autoimmune conditions such as rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, ulcerative colitis, psoriatic arthritis, and plaque psoriasis. Its extraordinary action offers significant relief for patients across hospital, prescription, and specialty care settings.


Packaging, Delivery and Export Details

Each infliximab vial features premium market value, carefully packaged in a single-use sterile vial for optimal safety. Delivered with tracked barcode and batch information for full traceability, the product is exported globally from India within a trusted delivery window. FOB at major ports ensures secure shipment and a high standard for the export market, meeting stringent international requirements for hospital supply and pharmaceutical distributors.


FAQ's of Infliximab Powder For Concentrate Solution For Infusion:


Q: How should Infliximab Powder be prepared for IV infusion?

A: Reconstitute the powder with sterile water for injection, then further dilute with 0.9% Sodium Chloride Injection. The solution must be filtered using a low-protein-binding 0.22 micron filter prior to infusion.

Q: What conditions is infliximab indicated for?

A: Infliximab is prescribed for the treatment of autoimmune disorders such as rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, ulcerative colitis, psoriatic arthritis, and plaque psoriasis.

Q: When should infliximab not be administered?

A: Infliximab should not be used in individuals with hypersensitivity to infliximab or murine proteins, nor in cases of severe active infections.

Q: Where should the product be stored before use?

A: Store unopened infliximab vials in a refrigerator at 2C to 8C, avoiding freezing and protecting them from light to maintain integrity.

Q: What is the process for disposing unused infliximab or waste materials?

A: Disposal of unused product and waste should follow local regulatory guidelines for pharmaceutical waste, ensuring environmental safety and compliance.

Q: How does barcode and batch tracking benefit users?

A: Barcode and batch tracking enhance traceability, ensuring the product's origin, authenticity, and allowing for efficient inventory management or recall processes if needed.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Injection Category

500 Mg - 50 Ml Rituximab

500 Mg - 50 Ml Rituximab

Price 6500 INR / Vial

Minimum Order Quantity : 1 Vial

Dosage Form : Injection

Salt Composition : Rituximab 500 mg

Storage Instructions : Store at 2C 8C. Do not freeze. Protect from light.

Indication : NonHodgkins lymphoma, Chronic lymphocytic leukemia, Rheumatoid arthritis, Granulomatosis with polyangiitis, Microscopic polyangiitis

100 Mg Cetuximab Injection

100 Mg Cetuximab Injection

Price 7000 INR / Vial

Minimum Order Quantity : 1 Vial

Dosage Form : Injection

Salt Composition : Cetuximab 100mg

Storage Instructions : Store at 2C to 8C, do not freeze

Indication : Colorectal cancer, Head and neck cancer

120 Mg Denosumab Injection IP

120 Mg Denosumab Injection IP

Price 21999 INR / Vial

Minimum Order Quantity : 1 Vial

Dosage Form : Injection

Salt Composition : Denosumab 120 mg

Storage Instructions : Store in a refrigerator at 2C to 8C. Do not freeze.

Indication : Osteoporosis, treatment of bone loss, prevention of skeletalrelated events in patients with bone metastases from solid tumors

11.25 Mg Triptorelin Acetate Injection

11.25 Mg Triptorelin Acetate Injection

Price 7999 INR / Vial

Minimum Order Quantity : 1 Vial

Dosage Form : Injection

Salt Composition : Triptorelin Acetate 11.25 mg

Storage Instructions : Store below 25C. Do not freeze. Protect from light.

Indication : Treatment of prostate cancer, endometriosis, uterine fibroids, and precocious puberty



Back to top